Avanos Medical Reports Results for Quarter Ended Mar 31, 2026

What Happened Avanos Medical, Inc. (AVNS) filed a Form 8-K on May 5, 2026 (Item 2.02) to furnish a press release announcing its results of operations for the three months ended March 31, 2026. The press release is included as Exhibit 99.1 to the filing and the cover page interactive data file is provided as Exhibit 104. The 8-K was signed by John J. Hurley, Controller and Principal Accounting Officer.

Key Details

• Filing date: May 5, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Period covered: results for the three months ended March 31, 2026.
• Press release furnished as Exhibit 99.1; interactive XBRL cover page filed as Exhibit 104.
• Signed by John J. Hurley, Controller (Principal Accounting Officer).

Why It Matters The company formally disclosed its quarterly operating results to the public through this 8-K, making any revenue, earnings, or other financial metrics released in the attached press release part of Avanos’ official filings. Investors should read the Exhibit 99.1 press release for the specific financial figures (revenue, profit/loss, and other metrics) and any management commentary, since this filing conveys the company’s most recent quarterly performance. Note: this 8-K only furnishes the press release (Item 2.02) and does not report other item types such as executive changes or transactions.